Michael Byrnes
2015 - Ocera Therapeutics
In 2015, Michael Byrnes earned a total compensation of $600.5K as Chief Financial Officer at Ocera Therapeutics.
Compensation breakdown
| Bonus | $5,130 |
|---|---|
| Non-Equity Incentive Plan | $104,880 |
| Option Awards | $197,285 |
| Salary | $285,000 |
| Other | $8,166 |
| Total | $600,461 |
Byrnes received $285K in salary, accounting for 47% of the total pay in 2015.
Byrnes also received $5.1K in bonus, $104.9K in non-equity incentive plan, $197.3K in option awards and $8.2K in other compensation.
Rankings
In 2015, Michael Byrnes' compensation ranked 10,143rd out of 13,638 executives tracked by ExecPay. In other words, Byrnes earned more than 25.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,143 out of 13,638 | 26th |
Division Manufacturing | 3,867 out of 5,190 | 26th |
Major group Chemicals And Allied Products | 1,420 out of 1,854 | 23rd |
Industry group Drugs | 1,166 out of 1,528 | 24th |
Industry Pharmaceutical Preparations | 914 out of 1,182 | 23rd |
Source: SEC filing on April 25, 2017.
Byrnes' colleagues
We found two more compensation records of executives who worked with Michael Byrnes at Ocera Therapeutics in 2015.